Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy.

MLA

Ravandi, Farhad, et al. “Characteristics and Outcome of Patients with Acute Myeloid Leukemia Refractory to 1 Cycle of High-Dose Cytarabine-Based Induction Chemotherapy.” Blood, vol. 116, no. 26, Dec. 2010, pp. 5818–23. EBSCOhost, https://doi.org/10.1182/blood-2010-07-296392.

APA

Ravandi, F., Cortes, J., Faderl, S., O’Brien, S., Garcia-Manero, G., Verstovsek, S., Santos, F. P. S., Shan, J., Brandt, M., de Lima, M., Pierce, S., & Kantarjian, H. (2010). Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy. Blood, 116(26), 5818–5823. https://doi.org/10.1182/blood-2010-07-296392

Chicago

Ravandi, Farhad, Jorge Cortes, Stefan Faderl, Susan O’Brien, Guillermo Garcia-Manero, Srdan Verstovsek, Fabio P S Santos, et al. 2010. “Characteristics and Outcome of Patients with Acute Myeloid Leukemia Refractory to 1 Cycle of High-Dose Cytarabine-Based Induction Chemotherapy.” Blood 116 (26): 5818–23. doi:10.1182/blood-2010-07-296392.